WeVote

Bill

Bill

S 4631

Increases penalty for crime of manufacturing, distributing, or dispensing certain Schedule I or II controlled dangerous substances.

2024-2025 Regular Session Introduced by Vince Polistina

New Jersey bill increases criminal penalties for manufacturing and distributing Schedule I and II controlled substances to strengthen drug trafficking enforcement.

Introduced in the Senate, Referred to Senate Judiciary Committee
0
WeVote Research Nonpartisan
Bill Summary · S 4631

Legislative bill overview

S 4631 increases criminal penalties for manufacturing, distributing, or dispensing Schedule I or II controlled substances in New Jersey. The bill enhances existing penalties, though the specific penalty increases are not detailed in the available summary. This represents a stricter enforcement approach to drug manufacturing and distribution crimes.

Why is this important

Sentencing enhancements for drug crimes directly impact incarceration rates and criminal justice system costs. This type of legislation reflects ongoing debates about whether harsher penalties effectively deter drug trafficking or simply increase prison populations, particularly affecting lower-income and minority communities historically subject to disparate drug enforcement.

Potential points of contention

  • Incarceration burden: Increased penalties may worsen prison overcrowding and state budget strain without evidence that longer sentences reduce drug availability or trafficking
  • Sentencing disparity concerns: Enhanced penalties could exacerbate existing racial and socioeconomic disparities in drug enforcement, as certain communities face disproportionate prosecution for similar offenses
  • Public health vs. criminal justice approach: Growing evidence supports treatment-focused responses to drug issues over purely punitive measures; this bill moves opposite that direction

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.